Literature DB >> 3343007

Non-cirrhotic portal hypertension with hypoxaemia.

C Babbs1, T W Warnes, N Y Haboubi.   

Abstract

Hypoxaemia and digital clubbing are rare but well recognised associations of hepatic cirrhosis with portal hypertension. We report the first European patient with idiopathic non-cirrhotic portal hypertension complicated by these features. Pulmonary physiological studies show the hypoxaemia to be the result of anatomical and physiological intrapulmonary shunting.

Entities:  

Mesh：

Year:  1988        PMID： 3343007      PMCID： PMC1433273          DOI： 10.1136/gut.29.1.129

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  11 in total

1.  Cyanotic syndrome of portal hypertension in hepatosplenic schistosomiasis and portal cirrhosis. Report of four cases.

Authors:  E J MARCHAND; M DE JESUS; Z A BIASCOECHEA
Journal:  Am J Cardiol       Date:  1962-10       Impact factor: 2.778

2.  Arterial oxygen unsaturation and the ventilation-perfusion defect of Laennec's cirrhosis.

Authors:  T RODMAN; M SOBEL; H P CLOSE
Journal:  N Engl J Med       Date:  1960-07-14       Impact factor: 91.245

3.  Arsenic and noncirrhotic portal hypertension.

Authors:  J S Morris; M Schmid; S Newman; P J Scheuer; S Sherlock
Journal:  Gastroenterology       Date:  1974-01       Impact factor: 22.682

Review 4.  Measurement of portal pressure and its clinical application.

Authors:  T B Reynolds; S Ito; S Iwatsuki
Journal:  Am J Med       Date:  1970-11       Impact factor: 4.965

5.  Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis).

Authors:  W P Mikkelsen; H A Edmondson; R L Peters; A G Redeker; T B Reynolds
Journal:  Ann Surg       Date:  1965-10       Impact factor: 12.969

6.  Slow cirrhosis--or no cirrhosis? a lesion causing benign intrahepatic portal hypertension.

Authors:  D A Levison; J G Kingham; A M Dawson; A G Stansfeld
Journal:  J Pathol       Date:  1982-07       Impact factor: 7.996

7.  Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi.

Authors:  P Berthelot; J G Walker; S Sherlock; L Reid
Journal:  N Engl J Med       Date:  1966-02-10       Impact factor: 91.245

8.  Portal hypertension in vinyl-chloride production workers.

Authors:  P M Smith; I R Crossley; D M Williams
Journal:  Lancet       Date:  1976-09-18       Impact factor: 79.321

9.  The pathology of noncirrhotic portal fibrosis: a review of 32 autopsy cases.

Authors:  B K Aikat; S R Bhusnurmath; P N Chhuttani; S K Mitra; D V Dutta
Journal:  Hum Pathol       Date:  1979-07       Impact factor: 3.466

10.  Structural alterations to the pulmonary circulation in fulminant hepatic failure.

Authors:  A Williams; P Trewby; R Williams; L Reid
Journal:  Thorax       Date:  1979-08       Impact factor: 9.139
View more
  10 in total

Review 1.  Differential diagnosis of hepatopulmonary syndrome (HPS): Portopulmonary hypertension (PPH) and hereditary hemorrhagic telangiectasia (HHT).

Authors:  Inna Krynytska; Mariya Marushchak; Anna Mikolenko; Anzhela Bob; Iryna Smachylo; Ludmyla Radetska; Olga Sopel
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

2.  [Hepatopulmonary syndrome].

Authors:  G P Glattki; C Maurer; N Satake; R Lange; K Metz; M Wettstein; U Costabel
Journal:  Med Klin (Munich)       Date:  1999-09-15

Review 3.  Noncirrhotic portal hypertension.

Authors:  Harshal Rajekar; Rakesh K Vasishta; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

4.  Arterial hypoxemia and intrapulmonary vasodilatation in rat models of portal hypertension.

Authors:  Yasumi Katsuta; Xue-Jun Zhang; Masaru Ohsuga; Toshio Akimoto; Hirokazu Komeichi; Shuji Shimizu; Yoshihito Kato; Akiko Miyamoto; Katsuaki Satomura; Teruo Takano
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

5.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

6.  Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome.

Authors:  Graciela Martinez-Palli; Britt B Drake; Joan-Carles Garcia-Pagan; Joan-Albert Barbera; Miguel R Arguedas; Robert Rodriguez-Roisin; Jaume Bosch; Michael B Fallon
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

7.  Intrapulmonary arteriovenous shunting may be a universal phenomenon in patients with the superior cavopulmonary anastomosis: a radionuclide study.

Authors:  J J Vettukattil; Z Slavik; R K Lamb; J L Monro; B R Keeton; V T Tsang; A J Aldous; A Zivanovic; S Johns; V Lewington; A P Salmon
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

8.  Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients.

Authors:  Sabahattin Kaymakoglu; Tevfik Kahraman; Hasan Kudat; Kadir Demir; Yilmaz Cakaloglu; Isik Adalet; Dinc Dincer; Fatih Besisik; Güngör Boztas; Ahmet Bilge Sözen; Zeynel Mungan; Atilla Okten
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

9.  Hepatopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry.

Authors:  Peter Deibert; Hans-Peter Allgaier; Stefanie Loesch; Claudia Müller; Manfred Olschewski; Hinrich Hamm; Klaus-Peter Maier; Hubert Erich Blum
Journal:  BMC Gastroenterol       Date:  2006-04-25       Impact factor: 3.067

10.  Left Ventricular Dilation and Pulmonary Vasodilatation after Surgical Shunt for Treatment of Pre-Sinusoidal Portal Hypertension.

Authors:  Orlando Luis de Andrade Santarém; Roberto de Cleva; Flávia Megumi Sasaya; Marianna Siqueira de Assumpção; Meive Santos Furtado; Alfonso Julio Guedes Barbato; Paulo Herman
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.